Thanks all for the kind words, I'm encouraged so m
Post# of 72446
Posted On: 05/10/2013 10:53:56 PM
Thanks all for the kind words, I'm encouraged so many share my opinion of the company. although I do respect and understand that there may be those that do not that are skeptics since my opinion is obviously very bullish.
As for today's volume, I believe its a combination of anticipation for the IDEAS conference, the ASCO abstract being posted on Wednesday, and an expectation of a good PR possibly over this weekend or early next week. My article certainly got its share of views today, but I think these near term events are all coming around at the same time and it has caused a surge of interest and buying. I had uploaded the article earlier in the week, but just got tied up with some edits the SA editors requested, so it worked out that they approved it and posted it later in the week.
As for the price move today, The exciting part is we are still waiting on a PR and there could be any number of excellent announcements piled in when that comes. It has been quite a while now since we've heard a trial update, which to me is very exciting as I believe the research team at DF is simply compiling and verifying what I think will be some excellent trial news. Very much looking forward to this next PR and next week with both IDEAS and ASCO abstract on deck!
As for today's volume, I believe its a combination of anticipation for the IDEAS conference, the ASCO abstract being posted on Wednesday, and an expectation of a good PR possibly over this weekend or early next week. My article certainly got its share of views today, but I think these near term events are all coming around at the same time and it has caused a surge of interest and buying. I had uploaded the article earlier in the week, but just got tied up with some edits the SA editors requested, so it worked out that they approved it and posted it later in the week.
As for the price move today, The exciting part is we are still waiting on a PR and there could be any number of excellent announcements piled in when that comes. It has been quite a while now since we've heard a trial update, which to me is very exciting as I believe the research team at DF is simply compiling and verifying what I think will be some excellent trial news. Very much looking forward to this next PR and next week with both IDEAS and ASCO abstract on deck!
(0)
(0)